Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) and Programmed Cell Death Protein 1 (PD-1)/Programmed Death Ligand 1 (PD-L1) are two prominent immune checkpoints known to impact the outcome of several tumor entities. The gene discussed is PDCD1; the disease is neoplasm.